2023
-
03
KIMES 2023
-
03
Dubai World Dermatology and Laser Conference & Exhibition
-
01
IMCAS World Congress 2023
BIOBIJOU
A beauty bio company created through innovation and challenge
Since 2018
A leading company with
globalizing the best value
2022
-
11
Biobijou Co., signed a strategic alliance for R&D with Moogene Medi Co., Ltd for a next generation medical device business, LNP filler.
-
11
Acquisition of the certificate of ISO14001:2015
-
10
Acquisition of the certificate of ISO22716:2007
2021
-
12
Chungdam Global Co., Ltd., and Biobijou Co. entered into a strategic alliance for R&D and distribution with Zerone Bio Co. through comprehensive technical cooperation.
-
09
Acquisition of the certificate of Excellent Technology Evaluation (T-3 grade) by Nice Information Service.
-
05
Acquisition of the certificate of ISO9001:2015
-
05
Agreement about spearheading into China with ExocoBio co., Ltd: “Regeneration Aesthetics (ASCE+)”
-
04
Acquisition of the certificate of authorization: Research Institute (Korea Industrial Technology Association)
-
04
Acquisition of the certificate of “Promising Export Firm” (The Ministry of SMEs and Startups)
-
03
Acquisition of medical device manufacturing license (The Ministry of Food and Drug Safety)
-
03
Acquisition of medical device manufacturing license (The Ministry of Food and Drug Safety of Gyeongin)
-
02
Awarded “$500 million Export Tower” on the 57th Trade Day Ceremony by Korea International Trade Association
-
02
Acquisition of the certificate of ISO13485:2016
-
02
Additional capital: KRW 1 billion (Total capital KRW 1.5 billion)
-
01
Acquisition of certificate of Excellent Technology Evaluation (T-5 grade) by Nice Information Service.
2020
-
11
Completion of Factory registration
-
09
Completion of manufacturing facility (GMP level)
-
07
Inauguration of Seok Ju Choi as CEO (Co-CEO)
-
06
Inauguration of Joon Ho Yang as CEO (Co-CEO)
2019
-
11
Change in corporate name: Biobijou Co.
-
09
Contract completion of manufacturing factory: Relocation into 7 buildings in Hanam Technovalley U1 Center
-
04
Acquisition of pharmaceutical wholesaler license (Gangnam-gu office)
-
03
Launching own beauty brand (COLENA, MIWELL, etc)
-
02
Additional capital: KRW 400 million (Total capital KRW 500 million)
2018
-
10
Sigend major vendor agreements with Daewoong Pharmaceutical Co., Ltd., Daehan Nupharm Co., Ltd., Medytox Inc., Hugel Inc., etc)
-
08
Distributor contract with PharmaResearch Co., Ltd.
-
07
Established JJ Medical Co., Ltd.
